Microcore

Collagen Type X

Collagen Type X Advanced Purification Technologies by Green Chemistry

Microcore has more than two decades of experiences in research, manufacturing and scale up of many Nutrabioceuticals and Therapeutics. Our new innovations helps us to develop unique and GRAS Green enzyme technologies for the purification of Collagen type X from Egg Shell Membrane.

Collagen Type X is a specialized, non-fibrillar collagen naturally present in the eggshell membrane (ESM). It plays a crucial role in bone and cartilage formation, particularly in the later stages of cartilage maturation.

Produced by hypertrophic chondrocytes, Type X collagen is a vital marker of cartilage development and endochondral ossification—the process by which soft cartilage is mineralized into hard bone. Its presence in egg membrane provides a unique natural source for joint and bone regenerative applications.

Collagen Type X Bone Mineralization Research

Significances

  • Marker of Cartilage Maturation: Produced by hypertrophic chondrocytes for advanced development.
  • Supports Bone Mineralization: Contributes to endochondral ossification (bone hardening).
  • Helps Joint Integrity: Reinforces the structure of weight-bearing joints.
  • Anti-inflammatory Potential: Natural bioactive peptides aid repair and reduce inflammation.

Frequently Asked Questions

  • Chondrocyte Activation: Enables proper cartilage maturation.
  • Matrix Mineralization: Deposition of calcium for bone strengthening.
  • Structural Support: Reinforces cartilage and subchondral bone.
  • Inflammation Modulation: Reduces inflammatory mediators like TNF-α.

  • Cartilage Development: Crucial for the maturation of joint tissues.
  • Bone Hardening: Supports the natural ossification process.
  • Natural Bioactive Source: Minimally processed and well-tolerated ESM source.
  • Synergistic Repair: Works with Types I and V for joint remodeling.

  1. 1. Chondrocyte Activation: Enhances the function of hypertrophic chondrocytes.
  2. 2. Matrix Mineralization: Facilitates essential calcium and phosphate deposition.
  3. 3. Structural Support: Works in synergy with Collagen I and V.
  4. 4. Inflammation Modulation: Helps reduce mediators like IL-1β and TNF-α.

The developments are at lab scale and expected to complete clinical studies and further launch by 2028.